 Connection
Francesca Cendali to Rats, Sprague-Dawley
This is a "connection" page, showing publications Francesca Cendali has written about Rats, Sprague-Dawley.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.115 |
|
|
|
-
Signoretti C, Matsumura S, Doja J, Fatehi S, Williams C, D'silva M, Cendali F, Dzieciatkowska M, D'Alessandro A, Lanier GM, Gupte SA. VEGFR-2 blocker induces pulmonary vascular disease in rats with CRISPR-edited human non-deficient G6PD polymorphism: role of 3D genomic modifications and DNA methylation. Br J Pharmacol. 2026 Aug; 183(16):4675-4697.
Score: 0.040
-
Signoretti C, Fatehi S, Drewes R, Cendali F, Dzieciatkowska M, D'Alessandro A, Bae Y, Gupte SA. Bleomycin-induced lung fibrosis and dysfunction is exacerbated by G6PD deficiency. Am J Physiol Lung Cell Mol Physiol. 2026 02 01; 330(2):L145-L158.
Score: 0.039
-
Signoretti C, Matsumura S, Fatehi S, D'Silva M, Mathew R, Cendali F, D'Alessandro A, Alam SMS, Garcia V, Miano JM, Gupte SA. G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease. J Am Heart Assoc. 2024 10; 13(19):e035174.
Score: 0.036
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|